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ABSTRACT
Antibiotic prophylaxis in oral and maxillofacial surgery aims the prevention of the infection of the surgical wound, 
either due to the characteristics of the surgery or the general state of the patient. This risk increases with the contami-
nation of the surgical operation area, making it necessary to imply a prophylactic treatment of the infection in clean-
contaminated and contaminated surgeries and treatment of the infection in dirty surgeries. Moreover, a proper surgical 
technique helps to reduce the development of the postsurgical infection. The elective antibiotic chemotherapy ranges 
from penicillin-derivates with betalactamase inhibitors (amoxycillin-clavulanate, ampicilin-sulbactam) to second or third 
generation cephalosporins, quinolones or clindamycin. The indication for the use of these antibiotics depends on the 
type of surgery in oral and maxillofacial surgery,  according to the degree of contamination. Thus in oral surgery and 
surgery of the salivary glands the literature demonstrates that there is not a better prognosis when using prophylactic 
antibiotherapy instead of not using it in healthy patients. In traumatology this prophylaxis is justified in compound 
fractures and those communicating with paranasal sinuses. In orthognatic surgery there is disagreement according  to the 
criteria of using antibiotic prophylaxis, but short term treatment is preferred in case of using it. In oncological surgery it 
has been demonstrated the reduce in incidence of postsurgical infection using prophylactic peroperative antibiotherapy, 
mostly in those cases in which oral mucosa and cervical area contact.
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RESUMEN
La profilaxis antibiótica en cirugía oral y maxilofacial tiene como fin la prevención de la infección en la herida quirúrgica, 
ya sea por las características de la cirugía o por el estado general del paciente. Este riesgo se incrementa cuanto más se 
contamine el campo quirúrgico, siendo necesario realizar tratamiento profiláctico de la infección en cirugías limpias-
contaminadas y contaminadas y tratamiento de la infección en cirugías sucias. Además, una adecuada técnica quirúrgica 
colabora con la reducción de la aparición de infección postquirúrgica. La antibioterapia de elección varía entre derivados 
de la penicilina con inhibidores de las betalactamasas (amoxicilina-clavulánico, ampicilina-sulbactam), cefalosporinas 
de segunda o tercera generación, quinolonas o clindamicina.  La indicación de su uso variará en función del tipo de 
cirugía en cada ámbito de la cirugía oral y maxilofacial, según el grado de contaminación de la misma. De este modo en 
cirugía oral y en patología de glándulas salivares la literatura parece demostrar que no hay mejor pronóstico en cuanto 
al uso de antibioterapia profiláctica respecto a no usarla en pacientes sanos. En traumatología se justifica en fracturas 
compuestas o con comunicación con senos paranasales. En cirugía ortognática hay discrepancia en cuanto al criterio 
de empleo de profilaxis antibiótica, si bien se prefieren ciclos cortos de tratamiento. En cuanto a la cirugía oncológica, 
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INTRODUCTION
The aim in surgical antibiotic prophylaxis is to prevent the 
possibility of an infection in the surgical wound, creating an 
area of resistance to microorganisms by means of antibiotic 
serum concentrations that may avoid the multiplication and 
spread of bacteria through the surgical injury. 
The prophylaxis is always indicated when there is an impor-
tant risk of infection, because of either the features of the 
operation or the local or general conditions of the patient. 
Among the factors that could be the cause for this infec-
tion, the ones that should be emphasized are the type and 
duration of the surgery and the surgical risk of the patient 
(ASA risk) due to his comorbidity: diabetes, nephropathies, 
hepatopathies (cirrhosis), cardiopathies, inmmunosupres-
sors (corticoids, radiotherapy, chemotherapy, previous 
infections undertreated or mistreated with other antibiot-
ics). Minor surgical procedures in healthy patients may not 
require prophylaxis.
When the surgical injury comes about with in the skin 
wound, the main physical barrier that stops the entrance of 
microorganisms into the body breaks down (1). Because of 
this event, these microorganisms penetrate and may colonize 
and cause infection of deep tissues (2). According to the 
amount of bacteria, the possibility of infection elevates, 
also depending on whether it is a clean, clean-contaminated, 
contaminated or dirty surgery. The more contamination in 
the wound, the more risk of postsurgical infection. 
The risk of contamination of the surgical area reduces with 
an appropriate surgical technique, a good health of  the 
patient, etc (3), (4), but the one that has been considered 
the most important factor is antibiotic prophylaxis. Anti-
biotics in surgery must be used just in those cases in which 
is indicated and the pharmacocynetics of the drug should 
be appropriate as well as the spectrum of bacteria.
Measures of control of the infection in the surgical tech-
nique in order to reduce the risk of infection are clean in-
cissions, mucoperiosteal flaps avoiding tearing the mucosa, 
constant irrigation to cool the surgical area and clean the 
debris, constant aspiration, careful haemostasis, avoid in-
juries with the needle of the local anesthesia, slow entrance 
of the anesthetic agent, drainages and surgical dressings 
when required… It must be underlined the importance 
of the entrance in the postoperative period of liquids and 
remains of food through the surgical wound, therefore it 
should be recommended to make mouthwashes after 24 
hour postoperative time onwards. 
A good prophylaxis happens when there are effective serum 
concentrations of the drug since the opening of the skin 
of mucosa until its closure. Due to this fact, the antibiotic 
should be used in the hour previous to the incision. The best 
moment is during the anaesthetic induction via intravenous. 
In case of long-lasting surgery, it could be necessary to re-
peat the antibiotic dose to keep therapeutic serum levels of 
the drug, according to the pharmacocynetics of each anti-
biotic. It is not well demonstrated that the use of antibiotics 
more than 24 hours after the surgery may reduce the risk 
of infection. Therefore, it is considered malpractice treating 
patients with these drugs over this period of time (5). 
CLASSIFICATION OF SURGICAL WOUNDS 
ACCORDING TO THE RISK OF CONTAMINA-
TION-INFECTION (6-10)
• Type I: clean wounds (no disruption of  mucosa such 
as the oral cavity): infection rate 1-4%. No prophylaxis 
or prophylaxis no longer than 24 hours with amoxicillin-
clavulanate as there is no benefit in using postoperative 
antibiotics.
• Type II: clean-contaminated wounds (disruption of 
mucosa such as the oral cavity or surgery in an inflamed 
area): infection rate 5-15%. Prophylaxis against gram + and 
anaerobic bacteria (11) (amoxicillin-clavulanate, cefazolin + 
anaerobicid (clindamycin or metronidazol) (12)).
o Amoxicillin-clavulanate 2 g, repeat dose if  long term 
surgery 1g/4h (13).
o Allergy to betalactamics. Clindamycin 600 mg + genta-
mycin 120 mg), repeat dose if  long term surgery every 4h. 
• Type III: contaminated wounds (oncological surgery in 
which both oral cavity and neck contact): rate infection 
16-25%. Prophylaxis against gram +, anaerobc bacteria 
and also gram –, which are not covered in clean and clean 
contaminated surgeries, using drugs such as ampicillin-sul-
bactam or piperacillin-tazobactam:
o Amoxicillin-clavulanate 2 g, repeat dose if  long term 
surgery 1 g/4h.
o Clindamycin 600 mg + cefazolin 2 g, repeat dose of 
clindamycin every 6h and 1 g/8h of cefazolin if  long term 
surgery. 
• Type IV: dirty and infected wounds. Rate infection 25%. 
Antibiotic treatment always, not prophylaxis. 
The use of antiseptics in the oral cavity reduces the amount 
of the bacteria in the surgical area, but has not demons-
trated to be effective in the prophylaxis of  the bacterial 
colonization. 
CLASSIFICATION OF SURGICAL OPERATIONS 
Surgical operations can be classified into two groups, accor-
ding to the presence or absence or microorganisms in the 
surgical area. Some examples in maxillofacial surgery are: 
1. Surgical operations with absence of  microorganisms: 
impacted teeth, exostosis, torus, odontogenic tumors, cysts 
(not infected), epulis, preprosthetic and preorthodontic 
se ha demostrado la reducción de la incidencia de infección postquirúrgica con el uso de antibioterapia profiláctica 
peroperatoria, fundamentalmente en los casos en que se pone en contacto la mucosa oral con la región cervical.
Palabras clave: Infección, cavidad oral, Antibioticos, cirugía oral, cirugía maxilofacial, profilaxis.
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surgery, closed maxillary fractures, salivary glands diseases, 
osteotomies, grafts, flaps…
2. Surgical operations with presence of microorganisms: 
third molar pericoronaritis, inflammatory cysts, teeth roots, 
granulomas, sialolithiasis, open fractures, traumatisms, con-
tusions, infection inside a tumor, radionecrosis, etc.  
ANTIBIOTIC PROPHYLAXIS IN DIFFERENT 
SURGICAL OPERATIONS IN ORAL AND MAXI-
LLOFACIAL SURGERY
Literature data are contradictory as some issues conclude 
that the reduction in postoperative complications in oral and 
maxillofacial surgery is mostly because of the improvement 
in the surgical technique rather that antibiotic prophylaxis. 
Per and postoperative prophylaxis is recommended in those 
cases in which there is high risk of infection or clinical signs 
of infection.
The chosen antibiotic must be effective against the bacteria 
usually found in the oral cavity and cervicofacial skin, such 
as Staphylococcus, Streptococcus, enteric and anaerobic 
bacteria. Thus there is a good coverage using penicillin de-
rivates combinated with betalactamase inhibitors (amoxici-
llin-clavulanate, ampicillin-sulbactam), though other drugs 
can be used such as second or third generation cephalos-
porins (cefazolin, cefoxitin, ceftriaxone) (14), chinolones 
or clindamycin.
The use of preoperative antiseptics in the oral cavity (chlor-
hexidine, iodine) may reduce the complications caused by 
the surgical trauma in the oral cavity, mostly in patients 
with heart valve diseases, alloplastic implants, bone grafts, 
immunodepression, elderly people or patients with bad oral 
hygiene (15). 
1.- Oral surgery
Infection rate is low and because of that, in healthy patients, 
most of the procedures in the oral cavity need no antibiotic 
prophylaxis. The use will be reduced to those cases in which 
there is active infection, patients with comorbidity or im-
munodepression (16).
- Impacted third molars: different issues demonstrate that 
the use of postoperative antibiotics doesn´t  improve the 
prognosis in the possibility of infection after the surgery. 
Howewer other authors seem to demonstrate the benefit 
of using prophylaxis antibiotic amoxicilin/clavulanate for 
those procedures requiring osteotomy (17)
- Implantology: it has not been demonstrated that using 
long term  antibiotherapy in postoperative implantology 
surgery improves the prognosis dealing with postoperative 
infection.
2.- Traumatology
It is widely accepted the use of antibiotic prophylaxis in 
compound fractures (18).
- Mandible and dentoalveolar fractures: the algorithms of 
antibiotic treatment are the classical ones used in cervicofa-
cial pathology (penicillin and its derivates, third generation 
cephalosporins). The treatment of non complicated fractu-
res does not seem to improve versus not using antibiothera-
py, though many professionals use them to take advantage 
to the possibility of infection so as to reduce their incidence 
(19-22). Antibiotic treatment in the first 72 hours is not ne-
cessary. Antibiotic treatment of the infective complications 
(abscesses, pseudoarthrosis, osteomyelitis…) is where there 
is more consensus, although in this case we talk about anti-
biotic treatment and not with prophylaxis (23-25).
- Orbital wall fractures: there is no consensus on whether 
using antibiotics or not (some authors defend it and others 
don´t) (26).
Third mid and upper fractures: third generation cephalos-
porins are used, treating those cases with liquorrhea (27), 
though the majority of fractures in this region of the face 
are considered complex or compounded, communicating 
the oral mucosa with other parts such as the paranasal si-
nuses. In this sense, under our experience, we would rather 
use prophylactic antibiotics since the very beginning of 
these fractures.
3.- Ortognatic surgery and preprosthetic surgert
They are considered clean-contaminated surgeries. Some 
issues have demonstrated the benefit of using postoperative 
antibiotic prophylaxis (penicillin, cephalosporins, that in 
fact does not improve the prognosis and are more expensive) 
(28, 29). Other authors seem to demonstrate that there are 
no evidences in the improvement of the prognosis dealing 
with infection using postoperative antibiotics, specially if  
they are used via oral (30).
There is a higher incidence in infections in bimaxillary 
surgery without antibiotic treatment (31).
Some issues have used levofloxacin oral or cefazolin via 
intravenous in mandibular osteotomies, but in the latter is 
better to use amoxicillin-clavulanate due to the high amount 
of resistant bacteria to cefazolin (32).
The period of antibiotic prophylaxis was established in pre-
vious issues in five days, but the incidence of postoperative 
infection is the same comparing one day versus five days, 
though there is a certain improvement in the morbidity 
keeping the prophylaxis for five days (33). 
4.- Salivary glands
In surgeries such as parotidectomy or submaxilectomy it 
has been clearly demonstrated that there is no effectiveness 
in using antibiotic prophylaxis (34).
5.- Oncological, reconstructive and cervical surgery 
It has been demonstrated that the use of peroperative an-
tibiotics reduces the incidence of postoperative infections. 
As in the previous examples, in cervical pathology and, 
overall, in oncological surgery, antibiotic prophylaxis that 
can be used are clindamycin combinated with cefazolin, 
cephalosporins, aminoglycosides, chinolones or penicillin 
derivates combinated with betalactamase inhibitors.
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The risk of infection comes about when there is a chance to 
put a clean area in contact with a contaminated one such as 
the oral cavity, because the main source of contamination in 
these patients is the saliva, that carries an important amount 
of bacteria. Other factors that may contribute are the bad 
general state of the patient, immunodepression, preoperative 
radiotherapy or chemotherapy, reconstructive flaps or those 
procedures that may expose tissues to ischemia or necrosis. 
The sources of microorganisms in these diseases are the 
saliva, the skin, the teeth and the tumor itself. Therefore 
the chosen antibiotic must cover not only the common mi-
croorganims of saliva, such as gram + and anaerobic ones, 
but also gram – commonly isolated in tumor (35). Most 
of the references in literature don´t take into account the 
coverage of gram – in head and neck oncological surgery, 
but recent issues associate a better prognosis when there is 
a prophylaxis against gram – . 
Prophylactic antibiotics could be gentamycin + clindamycin, 
that cover gram +, gram – and anaerobic microorganisms 
properly (cefazolin is not useful against anaerobic germs). 
Other alternatives are amoxicillin-clavulanate and ampicil-
lin-sulbactam that have the same spe
The duration of the treatment is not well standarized, de-
pending on the surgeon.
 The postoperarive antibiotherapy is kept till drainages are 
retired, though the drug is maintained in case of infection 
of the surgical wound, dehiscence or fistula.
PROPHYLAXIS IN BACTERIAL ENDOCARDITIS
It must be done in patients with high risk of endocarditis 
cardiopathies which may undergo a procedure with bacte-
raemia risk in oral and maxillofacial surgery. 
The elective antiobiotic is amoxicillin-clavulanate. In allergic 
patients, the alternative is clindamycin, clarithromicina or 
azytromicine. 
High risk of endocarditis cardiopathies:
1. High risk: endovascular prosthesis, previous endocarditis, 
complex congenital cyanotic cardiopathy or surgical syste-
mic-pulmonary fistula.
2. Moderate risk: other congenital cardiopathies, acquired 
valvulopathies, mitral valve prolapse with regurgitation, 
hypertrophyc miocardiopathy.
3. Low risk: ostium secundum interauricular communica-
tion, surgically repaired interauricular or interventricular 
communications, previous by-pass, mitral valve prolapse 
without regurgitation, pacemaker.
Those patients in high and moderate risk need prophylaxis whe-
never they undergo a procedure in the oral or maxillofacial area. 
The guidelines used recommend using the drug one hour via oral 
or thirty minutes via endovenous before the procedure.
Prophylaxis Adults Children 
Standard Amoxicillin 2 g vo or iv Amoxicillin 50 mg/kg vo. 
Clindamycin 600 mg vo Clindamycin 20 mg/kg vo 
Azytromicine 500 mg vo Azytromicine 15 mg/kg vo 
Allergy to 
betalactamics 
Clarithromicina 500 mg vo Clarithromicina 15 mg7kg vo 
Ampicillin 600 mg im or iv Ampicillin 50 mg/kg im or iv Oral 
intolerance Cefazolin 1 g im or iv Cefazolin 25 mg/kg im or iv 
Table 1. Antibiotic prophylaxis in bacterial endocarditis
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